Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1992-04-21
1993-10-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514811, 514813, 514909, 514910, 564304, 564347, A61K 31165
Patent
active
052505715
ABSTRACT:
The present invention provides (S)-norfluoxetine and pharmaceutically acceptable salts thereof capable of inhibiting the uptake of serotonin.
REFERENCES:
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4194009 (1980-05-01), Molloy et al.
patent: 4313896 (1982-02-01), Molloy et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4584404 (1986-04-01), Molloy et al.
patent: 4626549 (1986-12-01), Molloy et al.
Wong, et al., Acta Pharm. Nord., 2 (3), 771 (1990).
Robertson et al., J. Med. Chem., 31, 1412 (1988).
Wong et al., Drug Development Research, 6, 397 (1985).
Fuller et al., Pharmacology Biochemistry and Behavior, 24, 281 (1986).
Nash et al., Clin. Chem., 28(10), 2100 (1982).
Aronoff et al., Clin. Pharmacol. Ther., 36(1), 138 (1984).
Fuller Ray W.
Mitchell David
Robertson David W.
Stephenson Gregory A.
Wong David T.
Conrad Robert A.
Eli Lilly and Company
Jones Joseph A.
Raymond Richard L.
Whitaker Leroy
LandOfFree
(S)-norfluoxetine in method of inhibiting serotonin uptake does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (S)-norfluoxetine in method of inhibiting serotonin uptake, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (S)-norfluoxetine in method of inhibiting serotonin uptake will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1004346